Cargando…

Disparities in Timeliness of Endometrial Cancer Care: A Scoping Review

OBJECTIVE: We use the person-centered Pathway to Treatment framework to assess the scope of evidence on disparities in endometrial cancer stage at diagnosis. This report is intended to facilitate interventions, research, and advocacy that reduce disparities. DATA SOURCES: We completed a structured s...

Descripción completa

Detalles Bibliográficos
Autores principales: Najor, Anna, Melson, Valerie, Lyu, Junrui, Fadadu, Priyal, Bakkum-Gamez, Jamie, Sherman, Mark, Kaunitz, Andrew, Connor, Avonne, Destephano, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510803/
https://www.ncbi.nlm.nih.gov/pubmed/37734095
http://dx.doi.org/10.1097/AOG.0000000000005338
_version_ 1785108021206056960
author Najor, Anna
Melson, Valerie
Lyu, Junrui
Fadadu, Priyal
Bakkum-Gamez, Jamie
Sherman, Mark
Kaunitz, Andrew
Connor, Avonne
Destephano, Christopher
author_facet Najor, Anna
Melson, Valerie
Lyu, Junrui
Fadadu, Priyal
Bakkum-Gamez, Jamie
Sherman, Mark
Kaunitz, Andrew
Connor, Avonne
Destephano, Christopher
author_sort Najor, Anna
collection PubMed
description OBJECTIVE: We use the person-centered Pathway to Treatment framework to assess the scope of evidence on disparities in endometrial cancer stage at diagnosis. This report is intended to facilitate interventions, research, and advocacy that reduce disparities. DATA SOURCES: We completed a structured search of electronic databases: PubMed, EMBASE, Scopus, ClinicalTrials.gov, and Cochrane Central Register of Controlled Trials databases. Included studies were published between January 2000 and 2023 and addressed marginalized population(s) in the United States with the ability to develop endometrial cancer and addressed variable(s) outlined in the Pathway to Treatment. METHODS OF STUDY SELECTION: Our database search strategy was designed for sensitivity to identify studies on disparate prolongation of the Pathway to Treatment for endometrial cancer, tallying 2,171. Inclusion criteria were broad, yet only 24 studies addressed this issue. All articles were independently screened by two reviewers. TABULATION, INTEGRATION, AND RESULTS: Twenty-four studies were included: 10 on symptom appraisal, five on help seeking, five on diagnosis, and 10 on pretreatment intervals. Quality rankings were heterogeneous, between 3 and 9 (median 7.2) per the Newcastle–Ottawa Scale. We identified three qualitative, two participatory, and two intervention studies. Studies on help seeking predominantly investigate patient-driven delays. When disease factors were controlled for, delays of the pretreatment interval were independently associated with racism toward Black and Hispanic people, less education, lower socioeconomic status, and nonprivate insurance. CONCLUSIONS: Evidence gaps on disparities in timeliness of endometrial cancer care reveal emphasis of patient-driven help-seeking delays, reliance on health care–derived databases, underutilization of participatory methods, and a paucity of intervention studies. SYSTEMATIC REVIEW REGISTRATION: Given that PROSPERO was not accepting systematic scoping review protocols at the time this study began, this study protocol was shared a priori through Open Science Framework on January 13, 2021 (doi: 10.17605/OSF.IO/V2ZXY), and through peer review publication on April 13, 2021 (doi: https://doi.org/10.1186/s13643-021-01649-x).
format Online
Article
Text
id pubmed-10510803
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-105108032023-09-21 Disparities in Timeliness of Endometrial Cancer Care: A Scoping Review Najor, Anna Melson, Valerie Lyu, Junrui Fadadu, Priyal Bakkum-Gamez, Jamie Sherman, Mark Kaunitz, Andrew Connor, Avonne Destephano, Christopher Obstet Gynecol Gynecology OBJECTIVE: We use the person-centered Pathway to Treatment framework to assess the scope of evidence on disparities in endometrial cancer stage at diagnosis. This report is intended to facilitate interventions, research, and advocacy that reduce disparities. DATA SOURCES: We completed a structured search of electronic databases: PubMed, EMBASE, Scopus, ClinicalTrials.gov, and Cochrane Central Register of Controlled Trials databases. Included studies were published between January 2000 and 2023 and addressed marginalized population(s) in the United States with the ability to develop endometrial cancer and addressed variable(s) outlined in the Pathway to Treatment. METHODS OF STUDY SELECTION: Our database search strategy was designed for sensitivity to identify studies on disparate prolongation of the Pathway to Treatment for endometrial cancer, tallying 2,171. Inclusion criteria were broad, yet only 24 studies addressed this issue. All articles were independently screened by two reviewers. TABULATION, INTEGRATION, AND RESULTS: Twenty-four studies were included: 10 on symptom appraisal, five on help seeking, five on diagnosis, and 10 on pretreatment intervals. Quality rankings were heterogeneous, between 3 and 9 (median 7.2) per the Newcastle–Ottawa Scale. We identified three qualitative, two participatory, and two intervention studies. Studies on help seeking predominantly investigate patient-driven delays. When disease factors were controlled for, delays of the pretreatment interval were independently associated with racism toward Black and Hispanic people, less education, lower socioeconomic status, and nonprivate insurance. CONCLUSIONS: Evidence gaps on disparities in timeliness of endometrial cancer care reveal emphasis of patient-driven help-seeking delays, reliance on health care–derived databases, underutilization of participatory methods, and a paucity of intervention studies. SYSTEMATIC REVIEW REGISTRATION: Given that PROSPERO was not accepting systematic scoping review protocols at the time this study began, this study protocol was shared a priori through Open Science Framework on January 13, 2021 (doi: 10.17605/OSF.IO/V2ZXY), and through peer review publication on April 13, 2021 (doi: https://doi.org/10.1186/s13643-021-01649-x). Lippincott Williams & Wilkins 2023-10 2023-09-07 /pmc/articles/PMC10510803/ /pubmed/37734095 http://dx.doi.org/10.1097/AOG.0000000000005338 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Gynecology
Najor, Anna
Melson, Valerie
Lyu, Junrui
Fadadu, Priyal
Bakkum-Gamez, Jamie
Sherman, Mark
Kaunitz, Andrew
Connor, Avonne
Destephano, Christopher
Disparities in Timeliness of Endometrial Cancer Care: A Scoping Review
title Disparities in Timeliness of Endometrial Cancer Care: A Scoping Review
title_full Disparities in Timeliness of Endometrial Cancer Care: A Scoping Review
title_fullStr Disparities in Timeliness of Endometrial Cancer Care: A Scoping Review
title_full_unstemmed Disparities in Timeliness of Endometrial Cancer Care: A Scoping Review
title_short Disparities in Timeliness of Endometrial Cancer Care: A Scoping Review
title_sort disparities in timeliness of endometrial cancer care: a scoping review
topic Gynecology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510803/
https://www.ncbi.nlm.nih.gov/pubmed/37734095
http://dx.doi.org/10.1097/AOG.0000000000005338
work_keys_str_mv AT najoranna disparitiesintimelinessofendometrialcancercareascopingreview
AT melsonvalerie disparitiesintimelinessofendometrialcancercareascopingreview
AT lyujunrui disparitiesintimelinessofendometrialcancercareascopingreview
AT fadadupriyal disparitiesintimelinessofendometrialcancercareascopingreview
AT bakkumgamezjamie disparitiesintimelinessofendometrialcancercareascopingreview
AT shermanmark disparitiesintimelinessofendometrialcancercareascopingreview
AT kaunitzandrew disparitiesintimelinessofendometrialcancercareascopingreview
AT connoravonne disparitiesintimelinessofendometrialcancercareascopingreview
AT destephanochristopher disparitiesintimelinessofendometrialcancercareascopingreview